The monoclonal B7-H3 antibody that has been radiolabeled with lutetium-177—currently under investigation as part of a multicenter Phase 1/2 clinical trial (NCT04167618) in pediatric patients…
Hoag Memorial Hospital Presbyterian today announced that it met a key clinical trial milestone, enrolling the first two patients in a clinical study evaluating “Natural…
A team of clinical investigators at Memorial Sloan Kettering Cancer Center (MSKCC) have developed and conducted a first-in-human, Phase 1 clinical trial investigating regionally delivered,…
A prominent California Central Coast cancer practice called Pacific Cancer Care happens to be the largest hematology and oncology practice in the area. Based in…
GlaxoSmithKline and Merck KGaA announced a joint decision to terminate their global collaboration on bintrafusp alfa, effective September 30, 2021. Bintrafusp alfa is an investigational bifunctional fusion protein…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
